Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

NCT00286962 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DEVICE: MIP 2007C implantable insulin pump
DEVICE: continuous subcutaneous insulin infusion (CSII) or MDI

Sponsor

Medical Research Foundation, The Netherlands

Collaborators

[object Object]